FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772844083> ?p ?o ?g. }

• W2772844083 endingPage "472" @default.
• W2772844083 startingPage "462" @default.
• W2772844083 abstract "<b><i>Background:</i></b> People with diabetes and kidney disease have a high risk of cardiovascular events and progression of kidney disease. Sodium glucose co-transporter 2 inhibitors lower plasma glucose by reducing the uptake of filtered glucose in the kidney tubule, leading to increased urinary glucose excretion. They have been repeatedly shown to induce modest natriuresis and reduce HbA1c, blood pressure, weight, and albuminuria in patients with type 2 diabetes. However, the effects of these agents on kidney and cardiovascular events have not been extensively studied in patients with type 2 diabetes and established kidney disease. <b><i>Methods:</i></b> The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial aims to compare the efficacy and safety of canagliflozin ­versus placebo at preventing clinically important kidney and cardiovascular outcomes in patients with diabetes and established kidney disease. CREDENCE is a randomized, double-blind, event-driven, placebo-controlled trial set in in 34 countries with a projected duration of ∼5.5 years and enrolling 4,401 adults with type 2 diabetes, estimated glomerular filtration rate ≥30 to &#x3c;90 mL/min/1.73 m², and albuminuria (urinary albumin:creatinine ratio &#x3e;300 to ≤5,000 mg/g). The study has 90% power to detect a 20% reduction in the risk of the primary outcome (α = 0.05), the composite of end-stage kidney disease, doubling of serum creatinine, and renal or cardiovascular death. <b><i>Conclusion:</i></b> CREDENCE will provide definitive evidence about the effects of canagliflozin on renal (and cardiovascular) outcomes in patients with type 2 diabetes and established kidney disease. <b><i>Trial Registration:</i></b> EudraCT number: 2013-004494-28; ClinicalTrials.gov identifier: NCT02065791." @default.
• W2772844083 created "2017-12-22" @default.
• W2772844083 creator A5007025699 @default.
• W2772844083 creator A5012514694 @default.
• W2772844083 creator A5016263167 @default.
• W2772844083 creator A5016452405 @default.
• W2772844083 creator A5016584401 @default.
• W2772844083 creator A5026602252 @default.
• W2772844083 creator A5027520502 @default.
• W2772844083 creator A5031624913 @default.
• W2772844083 creator A5039432822 @default.
• W2772844083 creator A5045497276 @default.
• W2772844083 creator A5046130400 @default.
• W2772844083 creator A5051708137 @default.
• W2772844083 creator A5056130529 @default.
• W2772844083 creator A5067501872 @default.
• W2772844083 creator A5069849278 @default.
• W2772844083 creator A5069865054 @default.
• W2772844083 creator A5075162144 @default.
• W2772844083 creator A5087695265 @default.
• W2772844083 creator A5088394454 @default.
• W2772844083 creator A5089564545 @default.
• W2772844083 creator A5090437675 @default.
• W2772844083 date "2017-01-01" @default.
• W2772844083 modified "2023-10-16" @default.
• W2772844083 title "The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics" @default.
• W2772844083 cites W1835375518 @default.
• W2772844083 cites W1985406570 @default.
• W2772844083 cites W1990025047 @default.
• W2772844083 cites W2010538618 @default.
• W2772844083 cites W2012241721 @default.
• W2772844083 cites W2044773944 @default.
• W2772844083 cites W2056976690 @default.
• W2772844083 cites W2073789348 @default.
• W2772844083 cites W2103202569 @default.
• W2772844083 cites W2116974726 @default.
• W2772844083 cites W2126662750 @default.
• W2772844083 cites W2133169646 @default.
• W2772844083 cites W2146264128 @default.
• W2772844083 cites W2152096085 @default.
• W2772844083 cites W2161569030 @default.
• W2772844083 cites W2179831365 @default.
• W2772844083 cites W2252435576 @default.
• W2772844083 cites W2424539745 @default.
• W2772844083 cites W2475261460 @default.
• W2772844083 cites W2512006388 @default.
• W2772844083 cites W2527824850 @default.
• W2772844083 cites W2562717710 @default.
• W2772844083 cites W2575068279 @default.
• W2772844083 cites W2594590765 @default.
• W2772844083 cites W2626446274 @default.
• W2772844083 cites W71085387 @default.
• W2772844083 doi "https://doi.org/10.1159/000484633" @default.
• W2772844083 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5804835" @default.
• W2772844083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29253846" @default.
• W2772844083 hasPublicationYear "2017" @default.
• W2772844083 type Work @default.
• W2772844083 sameAs 2772844083 @default.
• W2772844083 citedByCount "184" @default.
• W2772844083 countsByYear W27728440832017 @default.
• W2772844083 countsByYear W27728440832018 @default.
• W2772844083 countsByYear W27728440832019 @default.
• W2772844083 countsByYear W27728440832020 @default.
• W2772844083 countsByYear W27728440832021 @default.
• W2772844083 countsByYear W27728440832022 @default.
• W2772844083 countsByYear W27728440832023 @default.
• W2772844083 crossrefType "journal-article" @default.
• W2772844083 hasAuthorship W2772844083A5007025699 @default.
• W2772844083 hasAuthorship W2772844083A5012514694 @default.
• W2772844083 hasAuthorship W2772844083A5016263167 @default.
• W2772844083 hasAuthorship W2772844083A5016452405 @default.
• W2772844083 hasAuthorship W2772844083A5016584401 @default.
• W2772844083 hasAuthorship W2772844083A5026602252 @default.
• W2772844083 hasAuthorship W2772844083A5027520502 @default.
• W2772844083 hasAuthorship W2772844083A5031624913 @default.
• W2772844083 hasAuthorship W2772844083A5039432822 @default.
• W2772844083 hasAuthorship W2772844083A5045497276 @default.
• W2772844083 hasAuthorship W2772844083A5046130400 @default.
• W2772844083 hasAuthorship W2772844083A5051708137 @default.
• W2772844083 hasAuthorship W2772844083A5056130529 @default.
• W2772844083 hasAuthorship W2772844083A5067501872 @default.
• W2772844083 hasAuthorship W2772844083A5069849278 @default.
• W2772844083 hasAuthorship W2772844083A5069865054 @default.
• W2772844083 hasAuthorship W2772844083A5075162144 @default.
• W2772844083 hasAuthorship W2772844083A5087695265 @default.
• W2772844083 hasAuthorship W2772844083A5088394454 @default.
• W2772844083 hasAuthorship W2772844083A5089564545 @default.
• W2772844083 hasAuthorship W2772844083A5090437675 @default.
• W2772844083 hasBestOaLocation W27728440831 @default.
• W2772844083 hasConcept C126322002 @default.
• W2772844083 hasConcept C126894567 @default.
• W2772844083 hasConcept C134018914 @default.
• W2772844083 hasConcept C159641895 @default.
• W2772844083 hasConcept C2775887513 @default.
• W2772844083 hasConcept C2776174234 @default.
• W2772844083 hasConcept C2777180221 @default.
• W2772844083 hasConcept C2777451236 @default.
• W2772844083 hasConcept C2778653478 @default.

• next